Lanier Tim 4
4 · Wright Medical Group N.V. · Filed Nov 22, 2019
Insider Transaction Report
Form 4
Lanier Tim
President, Upper Extremities
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-11-21−36,723→ 7,395 totalExercise: $21.24Exp: 2026-07-19→ Ordinary Shares (36,723 underlying) - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$21.24/sh+36,723$779,997→ 61,682 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$24.49/sh+3,671$89,903→ 71,876 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$27.86/sh+6,523$181,731→ 68,205 total - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−6,523→ 5,084 totalExercise: $27.86Exp: 2027-07-25→ Ordinary Shares (6,523 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−3,671→ 8,080 totalExercise: $24.49Exp: 2028-07-24→ Ordinary Shares (3,671 underlying) - Sale
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$29.49/sh−46,917$1,383,798→ 24,959 total
Footnotes (6)
- [F1]Exercise and sale of vested stock options in connection with 280G tax planning.
- [F2]Includes 3,946 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,251 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,739 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.52, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F5]This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F6]This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.